Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
暂无分享,去创建一个
Hasier Eraña | Joaquín Castilla | J. Castilla | H. Eraña | Vanesa Venegas | Jorge Moreno | Vanesa Venegas | Jorge Moreno | Hasier Eraña
[1] Yvonne S. Eisele,et al. The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain , 2011, Acta Neuropathologica.
[2] D. Cui,et al. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species , 2002, Pathology international.
[3] N. Shneider,et al. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. , 2011, The Journal of clinical investigation.
[4] B. Caughey,et al. Prions and the potential transmissibility of protein misfolding diseases. , 2013, Annual review of microbiology.
[5] Gordon Ws. Advances in veterinary research. , 1946 .
[6] N. Hunter,et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. , 2008, Blood.
[7] Ewout J. N. Groen,et al. Protein aggregation in amyotrophic lateral sclerosis , 2013, Acta Neuropathologica.
[8] N. Cashman,et al. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion , 2016, Scientific Reports.
[9] B. Caughey,et al. Effect of Glycosylphosphatidylinositol Anchor-dependent and -independent Prion Protein Association with Model Raft Membranes on Conversion to the Protease-resistant Isoform* , 2003, The Journal of Biological Chemistry.
[10] A. Kincaid,et al. Rapid Prion Neuroinvasion following Tongue Infection , 2003, Journal of Virology.
[11] Brian J. Wiltgen,et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-b , 2012 .
[12] M. Staufenbiel,et al. Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition , 2011, The Journal of Neuroscience.
[13] Jacob I. Ayers,et al. Experimental transmissibility of mutant SOD1 motor neuron disease , 2014, Acta Neuropathologica.
[14] Sebastian Brandner,et al. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy , 2015, Nature.
[15] B. Ghetti,et al. Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases , 2016, Scientific Reports.
[16] D. Geschwind,et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.
[17] Nicole F. Liachko,et al. Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy , 2010, The Journal of Neuroscience.
[18] Masato Hasegawa,et al. Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.
[19] M. Zabel,et al. A brief history of prions. , 2015, Pathogens and disease.
[20] P. Andersen,et al. Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. , 2013, Human molecular genetics.
[21] A. Espenes,et al. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[22] H. Wille,et al. Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change* , 2009, Journal of Biological Chemistry.
[23] P. Westermark,et al. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. Cohen,et al. Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.
[25] Björn Granseth,et al. Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid , 2012, The Journal of Neuroscience.
[26] P. Szekeres,et al. Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates , 2014, The Journal of Biological Chemistry.
[27] E. Bigio,et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Prusiner,et al. Genetics of prion diseases and prion diversity in mice. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[29] E. Mandelkow,et al. ‘Prion-Like’ Propagation of Mouse and Human Tau Aggregates in an Inducible Mouse Model of Tauopathy , 2010, Neurodegenerative Diseases.
[30] T. Matsui,et al. Experimental induction of amyloidosis by bovine amyloid fibrils in Sore Hock rabbits , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[31] B. Ghetti,et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain , 2013, Proceedings of the National Academy of Sciences.
[32] S. Prusiner,et al. Some speculations about prions, amyloid, and Alzheimer's disease. , 1984, The New England journal of medicine.
[33] J. Hardy,et al. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.
[34] Xuebing Ding,et al. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure , 2015, Oncotarget.
[35] T. Crow,et al. Experimental Induction of β‐Amyloid Plaques and Cerebral Angiopathy in Primates a , 1993 .
[36] Stephen J. DeArmond,et al. Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions , 2012, Proceedings of the National Academy of Sciences.
[37] B. Maddison,et al. Prion transmission , 2010, Prion.
[38] Yong-jian Liu,et al. FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration , 2011, PLoS genetics.
[39] Christian Ducrot,et al. Review on the epidemiology and dynamics of BSE epidemics. , 2008, Veterinary research.
[40] T. Golde,et al. Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein , 2013, Acta neuropathologica communications.
[41] Richard I. Morimoto,et al. Adapting Proteostasis for Disease Intervention , 2008, Science.
[42] J. Trojanowski,et al. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains , 2015, Acta Neuropathologica.
[43] Hans-Ulrich Demuth,et al. Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid , 2012, Nature.
[44] E. Hoover,et al. Chronic wasting disease of cervids: current knowledge and future perspectives. , 2015, Annual review of animal biosciences.
[45] S. Prusiner,et al. A Unifying Role for Prions in Neurodegenerative Diseases , 2012, Science.
[46] K. Shannon,et al. Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[47] M. Staufenbiel,et al. Multiple Factors Contribute to the Peripheral Induction of Cerebral β-Amyloidosis , 2014, The Journal of Neuroscience.
[48] M. Staufenbiel,et al. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. , 2007, The American journal of pathology.
[49] TIKVAH ALPER,et al. Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.
[50] Inga Kadish,et al. Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice , 2006, Neurobiology of Disease.
[51] A. Roher,et al. Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice , 2002, Peptides.
[52] S. Prusiner,et al. Viroids and prions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. Prusiner,et al. Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients , 2014, Proceedings of the National Academy of Sciences.
[54] Frank Baumann,et al. Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis , 2010, Science.
[55] S. Carver,et al. Detection of Chronic Wasting Disease Prions in Salivary, Urinary, and Intestinal Tissues of Deer: Potential Mechanisms of Prion Shedding and Transmission , 2011, Journal of Virology.
[56] B. Malissen,et al. Determining the role of mononuclear phagocytes in prion neuroinvasion from the skin , 2012, Journal of leukocyte biology.
[57] S. Prusiner,et al. Salivary prions in sheep and deer , 2012, Prion.
[58] Deyu Li,et al. TDP-43 is intercellularly transmitted across axon terminals , 2015, The Journal of cell biology.
[59] A. Chakrabartty,et al. Monomeric Cu,Zn-superoxide Dismutase Is a Common Misfolding Intermediate in the Oxidation Models of Sporadic and Familial Amyotrophic Lateral Sclerosis*[boxs] , 2004, Journal of Biological Chemistry.
[60] J. Trojanowski,et al. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice , 2015, Neurobiology of Disease.
[61] Ji-Eun Suk,et al. Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic Mice , 2011, Experimental neurobiology.
[62] J. Chapuis,et al. Quaternary Structure of Pathological Prion Protein as a Determining Factor of Strain-Specific Prion Replication Dynamics , 2013, PLoS pathogens.
[63] Richard D. Leapman,et al. Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.
[64] M. Goedert,et al. The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2000 .
[65] J. Castilla,et al. Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism , 2013, International journal of cell biology.
[66] P. Andersen,et al. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. , 2016, The Journal of clinical investigation.
[67] N. Ishiguro,et al. Transmission of Systemic AA Amyloidosis in Animals , 2014, Veterinary pathology.
[68] D. Walsh,et al. Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.
[69] J. Brion,et al. Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. , 1985, Journal of submicroscopic cytology.
[70] D. Mann,et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau , 2015, Acta Neuropathologica.
[71] J. Castilla,et al. Animal models for prion-like diseases. , 2015, Virus research.
[72] M. Jucker,et al. Exogenous seeding of cerebral beta-amyloid deposition in beta APP-transgenic rats , 2012 .
[73] X. Roucou,et al. Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization , 2013, Molecular Neurodegeneration.
[74] Brian Spencer,et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.
[75] P. Verstreken,et al. Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation. , 2015, Cell reports.
[76] Ruedi Aebersold,et al. A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.
[77] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[78] Adriano Aguzzi,et al. Prions: protein aggregation and infectious diseases. , 2009, Physiological reviews.
[79] Gregor Bieri,et al. Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1 , 2016, Acta Neuropathologica.
[80] L. Lannfelt,et al. NEURON-TO-NEURON TRANSMISSION OF ALPHA-SYNUCLEIN , 2014, Alzheimer's & Dementia.
[81] V. Lee,et al. Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles* , 2011, The Journal of Biological Chemistry.
[82] M. Goedert,et al. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. , 2000, Annals of the New York Academy of Sciences.
[83] G. Legname,et al. Prion Protein-Specific Antibodies-Development, Modes of Action and Therapeutics Application , 2014, Viruses.
[84] M. Margittai,et al. Amplification of Tau Fibrils from Minute Quantities of Seeds , 2014, Biochemistry.
[85] Sofia Nyström,et al. Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[86] Charles Duyckaerts,et al. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.
[87] T. Alper,et al. The exceptionally small size of the scrapie agent. , 1966, Biochemical and biophysical research communications.
[88] L. Grinberg,et al. Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.
[89] R. Ridley,et al. Very long term studies of the seeding of beta-amyloidosis in primates. , 2006, Journal of neural transmission.
[90] S. Prusiner,et al. Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.
[91] Armin Giese,et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[92] M. Cookson,et al. α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[93] M. Goedert,et al. Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice , 2013, Acta Neuropathologica.
[94] Mark Head,et al. Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .
[95] Robert H. Brown,et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. , 2010, Human molecular genetics.
[96] P. Tsvetkov,et al. Peripherally Applied Synthetic Peptide isoAsp7-Aβ(1-42) Triggers Cerebral β-Amyloidosis , 2013, Neurotoxicity Research.
[97] P E Fraser,et al. A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[98] J. Rumfeldt,et al. Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[99] R. Marsh,et al. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent , 1992, Journal of virology.
[100] A. Einstein,et al. Superoxide dismutase 1 and amyotrophic lateral sclerosis , 2005 .
[101] E. Kandel,et al. A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.
[102] Jane Y. Wu,et al. A Drosophila model for TDP-43 proteinopathy , 2010, Proceedings of the National Academy of Sciences.
[103] W. S. Gordon. Advances in veterinary research. , 1946, The Veterinary record.
[104] C. Soto,et al. Aggregate-Depleted Brain Fails to Induce Aβ Deposition in a Mouse Model of Alzheimer's Disease , 2014, PloS one.
[105] T. Crow,et al. Experimental induction of beta-amyloid plaques and cerebral angiopathy in primates. , 1993, Annals of the New York Academy of Sciences.
[106] A. Aguzzi,et al. Cell Biology of Prions and Prionoids: A Status Report. , 2016, Trends in cell biology.
[107] T. Crow,et al. Induction of β(A4)-amyloid in primates by injection of Alzheimer’s disease brain homogenate , 2007, Molecular Neurobiology.
[108] J. Trojanowski,et al. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells , 2009, Proceedings of the National Academy of Sciences.
[109] John Q Trojanowski,et al. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. , 2010, The American journal of pathology.
[110] J. Kordower,et al. Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat , 2011, Neurobiology of Disease.
[111] M. Bruce. TSE strain variation. , 2003, British medical bulletin.
[112] Tapan P. Patel,et al. Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.
[113] J. Ironside,et al. Variant CJD , 2014, Journal of the Neurological Sciences.
[114] Armin Giese,et al. Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding , 2007, The Journal of Neuroscience.
[115] B. Chesebro,et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain , 1985, Nature.
[116] P. Westermark,et al. Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis , 2009, FEBS letters.
[117] M. Diamond,et al. Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.
[118] B. Caughey,et al. Uptake and Neuritic Transport of Scrapie Prion Protein Coincident with Infection of Neuronal Cells , 2022 .
[119] A. Gitler,et al. Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS , 2011, PLoS biology.
[120] Noo Li Jeon,et al. β‐Amyloid is transmitted via neuronal connections along axonal membranes , 2014, Annals of neurology.
[121] D. Taylor. Inactivation of prions by physical and chemical means. , 1999, The Journal of hospital infection.
[122] N. Maragakis,et al. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo , 2011, Proceedings of the National Academy of Sciences.
[123] M. Groschup,et al. Spread of classic BSE prions from the gut via the peripheral nervous system to the brain. , 2012, The American journal of pathology.
[124] A. Aguzzi,et al. Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. , 2016, Swiss medical weekly.
[125] S. Prusiner,et al. Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice , 2014, Proceedings of the National Academy of Sciences.
[126] J. Griffith,et al. Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.
[127] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[128] J. Trojanowski,et al. Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy , 2013, The Journal of Neuroscience.
[129] John Bartlett,et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .
[130] J. Lah,et al. Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats , 2012, Journal of neurochemistry.
[131] P. Roller,et al. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. , 1993, The Journal of biological chemistry.
[132] G. Bloom,et al. Alzheimer disease , 2013, Prion.
[133] J. Jia,et al. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS , 2012, Molecular Neurodegeneration.
[134] A. Aguzzi,et al. Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation , 2009, Proceedings of the National Academy of Sciences.
[135] K. Ando,et al. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. , 2010, Biochemical Society transactions.
[136] C. Anfinsen. Principles that govern the folding of protein chains. , 1973, Science.
[137] D. Mann,et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. , 2013, Cell reports.
[138] E A Hoover,et al. Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). , 1999, The Journal of general virology.
[139] Rebecca B. Smith,et al. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. , 2013, Human molecular genetics.
[140] A. Zlotnick,et al. One protein, at least three structures, and many functions. , 2013, Structure.
[141] M. Hasegawa,et al. Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils* , 2016, The Journal of Biological Chemistry.
[142] Brian C Coe,et al. Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates , 2014, The Journal of Neuroscience.
[143] M. Diamond,et al. Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43* , 2010, The Journal of Biological Chemistry.
[144] Kurt Giles,et al. Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer's disease , 2011, Proceedings of the National Academy of Sciences.
[145] K. Ando,et al. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. , 2011, The American journal of pathology.
[146] H. Fraser,et al. Scrapie strain variation and its implications. , 1991, Current topics in microbiology and immunology.
[147] A. Gitler,et al. TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity* , 2009, The Journal of Biological Chemistry.
[148] J. Collinge,et al. Superoxide Dismutase 1 and tgSOD1G93A Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis , 2010, PloS one.
[149] R. Hauser,et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.
[150] Dennis W. Dickson,et al. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.
[151] A. Björklund,et al. Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo , 2012, PloS one.
[152] A. Goldberg,et al. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry , 2011, The EMBO journal.
[153] A. Aguzzi,et al. Mice devoid of PrP are resistant to scrapie , 1993, Cell.
[154] E. Marcello,et al. Modeling Alzheimer’s disease: from past to future , 2013, Front. Pharmacol..
[155] S. Gustincich,et al. Defined α-synuclein prion-like molecular assemblies spreading in cell culture , 2014, BMC Neuroscience.
[156] Michael Wolff,et al. Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology , 2009, Journal of neurochemistry.
[157] M. Halliday,et al. Prions: Generation and Spread Versus Neurotoxicity , 2014, The Journal of Biological Chemistry.
[158] David S Wishart,et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells , 2011, Proceedings of the National Academy of Sciences.
[159] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[160] J. Griffith,et al. Self-replication and scrapie. , 1967, Nature.
[161] Mostafa Langarizadeh,et al. A novel method for fuzzy diagnostic system design , 2018, Medical journal of the Islamic Republic of Iran.
[162] D. Cleveland,et al. The Seeds of Neurodegeneration: Prion-like Spreading in ALS , 2011, Cell.
[163] Clemens F. Kaminski,et al. Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology* , 2013, The Journal of Biological Chemistry.
[164] Nicolas Chenouard,et al. Prions hijack tunnelling nanotubes for intercellular spread , 2009, Nature Cell Biology.
[165] U. Sengupta,et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau , 2012, Scientific Reports.
[166] A. Heiseke,et al. Autophagy, prion infection and their mutual interactions. , 2010, Current issues in molecular biology.
[167] E. Waxman,et al. A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation , 2010, Journal of neurochemistry.
[168] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[169] T. Baron. Mouse models of prion disease transmission. , 2002, Trends in molecular medicine.
[170] R. Barker,et al. Anti-amyloid Compounds Inhibit α-Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification (PMCA)* , 2014, The Journal of Biological Chemistry.
[171] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[172] J. Collinge,et al. Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS , 2015, PLoS pathogens.
[173] Jun-tao Guo,et al. Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis , 2002, The Journal of Neuroscience.
[174] Michael W. Miller,et al. Prion disease: Horizontal prion transmission in mule deer , 2003, Nature.
[175] J. Mitchison. Cell Biology , 1964, Nature.
[176] F. Kametani,et al. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease , 2008, Proceedings of the National Academy of Sciences.
[177] Hans-Ulrich Demuth,et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology , 2008, Nature Medicine.
[178] B. Meier,et al. Structural and functional characterization of two alpha-synuclein strains , 2013, Nature Communications.
[179] C. Olanow,et al. Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder? , 2013, Movement disorders : official journal of the Movement Disorder Society.
[180] D. D. Di Monte,et al. Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury , 2015, Acta neuropathologica communications.
[181] Arturo Casadevall,et al. Host-Pathogen Interactions: Basic Concepts of Microbial Commensalism, Colonization, Infection, and Disease , 2000, Infection and Immunity.
[182] P. Liberski,et al. Kuru: Its ramifications after fifty years , 2009, Experimental Gerontology.
[183] R. Will,et al. Laboratory diagnosis of variant Creutzfeldt–Jakob disease , 2000, Histopathology.
[184] J. Winderickx,et al. Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies , 2014, Acta neuropathologica communications.
[185] M. Staufenbiel,et al. Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice , 2007 .
[186] M. Murray,et al. Transmission of Soluble and Insoluble &agr;-Synuclein to Mice , 2015, Journal of neuropathology and experimental neurology.
[187] Elisabet Englund,et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.
[188] Bin Zhang,et al. Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.
[189] John Q. Trojanowski,et al. Amyotrophic lateral sclerosis—a model of corticofugal axonal spread , 2013, Nature Reviews Neurology.
[190] E. Chang,et al. Diffusible amyloid oligomers trigger systemic amyloidosis in mice. , 2008, The Biochemical journal.
[191] E. Masliah,et al. Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[192] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[193] Christian Münch,et al. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells , 2011, Proceedings of the National Academy of Sciences.
[194] Lawrence Rajendran,et al. The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids , 2009, Neuron.
[195] D. Dickson,et al. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis , 2012, Molecular Neurodegeneration.
[196] P. Brown. Iatrogenic Creutzfeldt-Jakob disease. , 1990, Australian and New Zealand journal of medicine.
[197] R. Baloh. TDP‐43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration , 2011, The FEBS journal.
[198] J. Linehan,et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic , 2013 .
[199] T. Golde,et al. Conformational templating of α-synuclein aggregates in neuronal-glial cultures , 2013, Molecular Neurodegeneration.
[200] L. Schonberger,et al. Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment , 2012, Emerging infectious diseases.
[201] J. Castilla,et al. In Vitro Generation of Infectious Scrapie Prions , 2005, Cell.
[202] M. Simmons,et al. Disease characteristics of bovine spongiform encephalopathy following inoculation into mice via three different routes , 2013, International journal of experimental pathology.
[203] M. Spillantini,et al. Frontotemporal Dementia with Tau Pathology , 2007, Neurodegenerative Diseases.
[204] J. Chapuis,et al. Efficient dissemination of prions through preferential transmission to nearby cells. , 2007, The Journal of general virology.
[205] A. Karch,et al. On the issue of transmissibility of Alzheimer disease , 2012, Prion.
[206] R. Cappai,et al. Packaging of prions into exosomes is associated with a novel pathway of PrP processing , 2007, The Journal of pathology.
[207] M. Neunlist,et al. Activity‐dependent secretion of alpha‐synuclein by enteric neurons , 2013, Journal of neurochemistry.
[208] G. Baron,et al. GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells , 2010, The EMBO journal.
[209] N. Kanu,et al. Transfer of Scrapie Prion Infectivity by Cell Contact in Culture , 2002, Current Biology.
[210] E. M. Jones,et al. Fibril Conformation as the Basis of Species- and Strain-Dependent Seeding Specificity of Mammalian Prion Amyloids , 2005, Cell.
[211] W. Faigle,et al. Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[212] T. Crow,et al. Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. , 1993, International journal of experimental pathology.
[213] A. Buschmann,et al. Rodent models for prion diseases. , 2008, Veterinary research.
[214] A. Salazar,et al. Alzheimer's Disease and Transmissible Virus Dementia (Creutzfeldt‐Jakob Disease) , 1982, Annals of the New York Academy of Sciences.
[215] A. Hill,et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms , 2014, Proceedings of the National Academy of Sciences.
[216] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[217] Jacob I. Ayers,et al. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways , 2015, Acta Neuropathologica.
[218] Y. Ling. Experimental production of amyloidosis in ducks. , 1992, Avian pathology : journal of the W.V.P.A.
[219] J. Trojanowski,et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.
[220] S. Prusiner,et al. Identification of a protein that purifies with the scrapie prion. , 1982, Science.
[221] Ronald Melki,et al. Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport , 2012, Annals of neurology.
[222] K. Nilsson,et al. Seeded strain‐like transmission of β‐amyloid morphotypes in APP transgenic mice , 2013, EMBO reports.
[223] Fei Wang,et al. Generating a Prion with Bacterially Expressed Recombinant Prion Protein , 2010, Science.
[224] L. Greensmith,et al. A Nonsense Mutation in Mouse Tardbp Affects TDP43 Alternative Splicing Activity and Causes Limb-Clasping and Body Tone Defects , 2014, PloS one.
[225] J. Julien,et al. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis , 2007, Proceedings of the National Academy of Sciences.
[226] Chen Wang,et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity , 2011, Nature Structural &Molecular Biology.
[227] P. Westermark,et al. Amyloidogenic potential of foie gras , 2007, Proceedings of the National Academy of Sciences.
[228] Ji Han Kim,et al. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. , 2011, Human molecular genetics.
[229] D. Vaux,et al. Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease , 2007, PloS one.
[230] J. Šponarová,et al. AA-Amyloidosis Can Be Transferred by Peripheral Blood Monocytes , 2008, PloS one.
[231] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[232] Martin Hallbeck,et al. Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance , 2014, Neurobiology of Disease.
[233] P. Harrison,et al. Classifying prion and prion-like phenomena , 2014, Prion.
[234] J. Castilla,et al. De novo induction of amyloid-β deposition in vivo , 2012, Molecular Psychiatry.
[235] P. Baatsen,et al. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo , 2016, Acta Neuropathologica.
[236] T. Hortobágyi,et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion , 2012, Acta Neuropathologica.
[237] M. Samsonova,et al. Conservative system for dosage-dependent modulation of translational fidelity in eukaryotes. , 1992, Biochimie.
[238] Zeshan Ahmed,et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity , 2014, Acta Neuropathologica.
[239] R. Marsh,et al. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.
[240] N. Nukina,et al. A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions*♦ , 2011, The Journal of Biological Chemistry.
[241] I. Pattison. RESISTANCE OF THE SCRAPIE AGENT TO FORMALIN. , 1965, Journal of comparative pathology.
[242] F. Kametani,et al. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. , 2016, Human molecular genetics.